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ABSTRACT
CRISIS IN ENERGY METABOLISM
MITOCHONDRIAL DEFECTS AND A NEW DISEASE ENTITY
Gittan Kollberg, Department of Pathology, Institute of Biomedicine, The Sahlgrenska
Academy at Göteborg University, SE-413 45 Göteborg, Sweden
Impairment of energy metabolism may be associated with severe implications for
affected individuals since all fundamental cell functions are energy-dependent. Disorders of
energy metabolism are often genetic and associated with defects in the oxidative
phosphorylation in mitochondria. This thesis addresses the pathogenesis in some
mitochondrial disorders and a new disease entity associated with defects in the glycogen
metabolism.
In paper I we report on a primary mutation in mitochondrial DNA. We identified a
TÆC mutation at position 582 in the gene for tRNAPhe in a case of mitochondrial myopathy.
The mutation alters a conserved base pairing in the aminoacyl stem of the tRNA. By analysis
of single muscle fibers we showed that the level of heteroplasmy (proportion of mutant
mtDNA) was higher in muscle fibers with defective cytochrome c oxidase (COX) activity
compared to normal muscle fibers. Based on these findings we conclude that this mutation
was responsible for the disease.
In paper II we investigated a 30-year-old woman, who presented with an attack of acute
rhabdomyolysis. We found an isolated deficiency of COX and a novel nonsense mutation in
mtDNA in the gene encoding COX subunit I. In addition to its catalytic function, our data
clearly indicates an important function of subunit I for the assembly of COX. The mutation
was restricted to the patient’s muscle, but was not detectable in myoblasts, cultured from
satellite cells isolated from affected muscle tissue. This result may have interesting
implications for the natural evolution of the disease and perhaps therapy, since regenerating
muscle occurs by proliferation of satellite cells.
In paper III we investigated patients with mitochondrial diseases (progressive external
ophthalmoplegia, PEO) due to primary mutations in POLG1 encoding mtDNA polymerase
gamma (Polg) and secondary multiple mtDNA deletions.  The results show that it is very
unlikely that mtDNA point mutations contribute to the pathogenesis in PEO patients with
primary POLG1 mutations, and that the mechanism by which mutant Polg cause mtDNA
deletions does not involve mtDNA point mutations as an intermediate step, as has been
previously proposed.
In paper IV mtDNA alterations and pathology of muscle, brain and liver was
investigated in children with Alpers-Huttenlocher syndrome (AHS), a fatal neurodegenerative
disease associated with liver failure. All children had compound heterozygous missense
mutations in POLG1 . We provide evidence that AHS is a mitochondrial disease by
demonstrating mtDNA alterations (reduced mtDNA copy number and multiple mtDNA
deletions). Liver disease was triggered by valproate treatment in several cases possibly due to
severe respiratory chain deficiency, which was demonstrated in liver tissue in one case.
In paper V we report on a new disease entity “Muscle glycogen storage disease type
zero” due to a homozygous stop mutation in the muscle glycogen synthase gene (GYS1). We
performed investigations on a family where one child suffered sudden cardiac death at the age
of 10 and his younger brother showed muscle fatigability and hypertrophic cardiomyopathy.
In muscle there was a profound glycogen deficiency and an almost total predominance of
oxidative muscle fibers.
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